We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
1526
DELISTED
DermTech, Inc. Common Stock
DMTK
| $989K | ﹤0.01% |
249,800
-53,800
| -18% | -$331K |
|
1527
Shore Bancshares
SHBI
$820M
| $987K | ﹤0.01% |
57,000
-53,900
| -49% | -$1.02M |
|
1528
Capital City Bank Group
CCBG
$897M
| $986K | ﹤0.01% |
31,700
+12,300
| +63% | +$391K |
|
1529
MYR Group
MYRG
$5.01B
| $983K | ﹤0.01% |
11,600
+2,500
| +27% | +$229K |
|
1530
National Health Investors
NHI
$3.79B
| $978K | ﹤0.01% |
+17,300
| New | +$1.09M |
|
1531
Kopin
KOPN
$586M
| $972K | ﹤0.01% |
926,051
-437,149
| -32% | -$611K |
|
1532
Quanex
NX
$825M
| $972K | ﹤0.01% |
53,500
-7,500
| -12% | -$170K |
|
1533
PC Connection
CNXN
$2.09B
| $969K | ﹤0.01% |
21,500
+12,200
| +131% | +$576K |
|
1534
Hims & Hers Health
HIMS
$5.79B
| $967K | ﹤0.01% |
173,300
+17,600
| +11% | +$106K |
|
1535
AMC Entertainment Holdings
AMC
$2.45B
| $965K | ﹤0.01% |
13,843
+609
| +5% | +$83.2K |
|
|
EXTN
1536
DELISTED
Exterran Corporation
EXTN
| $963K | ﹤0.01% |
231,600
-90,300
| -28% | -$391K |
|
1537
Innospec
IOSP
$2.09B
| $960K | ﹤0.01% |
11,200
-2,700
| -19% | -$255K |
|
1538
Universal Technical Institute
UTI
$2.26B
| $960K | ﹤0.01% |
176,500
-36,100
| -17% | -$253K |
|
1539
BayCom
BCML
$335M
| $956K | ﹤0.01% |
54,400
-21,500
| -28% | -$415K |
|
1540
Blackbaud
BLKB
$1.94B
| $956K | ﹤0.01% |
21,700
+2,100
| +11% | +$113K |
|
1541
Phibro Animal Health
PAHC
$1.5B
| $954K | ﹤0.01% |
71,800
+25,600
| +55% | +$442K |
|
1542
AngioDynamics
ANGO
$605M
| $951K | ﹤0.01% |
+46,500
| New | +$1.02M |
|
|
MOMO
1543
Hello Group
MOMO
$867M
| $937K | ﹤0.01% |
202,900
+30,400
| +18% | +$146K |
|
|
CSW
1544
CSW Industrials
CSW
$4.44B
| $934K | ﹤0.01% |
7,800
+3,900
| +100% | +$477K |
|
|
ABST
1545
DELISTED
Absolute Software Corp
ABST
| $930K | ﹤0.01% |
80,114
+26,100
| +48% | +$266K |
|
1546
Financial Institutions
FISI
$812M
| $929K | ﹤0.01% |
38,587
-4,400
| -10% | -$114K |
|
|
NBP
1547
NovaBridge Biosciences American Depositary Shares
NBP
$186M
| $927K | ﹤0.01% |
231,200
+136,300
| +144% | +$1.03M |
|
1548
iShares Russell 1000 ETF
IWB
$47.1B
| $927K | ﹤0.01% |
4,700
-500
| -10% | -$110K |
|
|
IMOS
1549
ChipMOS TECHNOLOGIES
IMOS
$1.59B
| $926K | ﹤0.01% |
49,958
+30,700
| +159% | +$693K |
|
|
NETI
1550
DELISTED
Eneti Inc.
NETI
| $925K | ﹤0.01% |
138,700
-42,500
| -23% | -$302K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.